Brevan Howard Capital Management’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.09M Sell
11,425
-4,867
-30% -$467K 0.01% 1010
2026
Q1
$1.69M Buy
16,292
+12,767
+362% +$1.45M 0.01% 637
2025
Q4
$355K Buy
+3,525
New +$383K ﹤0.01% 1281
2025
Q3
– Sell
-56,977
Closed -$6.84M – 1977
2025
Q2
$6.84M Buy
56,977
+37,694
+195% +$5.03M 0.04% 264
2025
Q1
$2.84M Buy
+19,283
New +$2.94M 0.03% 234
2024
Q4
– Sell
-19,469
Closed -$3.17M – 1093
2024
Q3
$3.17M Buy
19,469
+11,196
+135% +$1.66M 0.02% 184
2024
Q2
$1.13M Buy
8,273
+3,522
+74% +$489K 0.01% 336
2024
Q1
$727K Buy
4,751
+813
+21% +$121K 0.01% 354
2023
Q4
$562K Buy
+3,938
New +$525K 0.01% 428

Other funds holding CLX

Brevan Howard Capital Management's CLX Position: Q2 2026 in Review

Brevan Howard Capital Management reduced its Clorox (CLX) stake by 30% in Q2 2026, selling an estimated $467K and leaving 11,425 shares worth $1.09M. The position accounts for 0.01% of the portfolio, ranked #1010.

Brevan Howard Capital Management first reported a position in CLX in Q4 2023 and has held it in 9 quarters since. The position peaked at $6.84M in Q2 2025. 1,055 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

  • Brevan Howard Capital Management held 11,425 shares of Clorox worth $1.09M as of Q2 2026.
  • Brevan Howard Capital Management sold 4,867 Clorox shares in Q2 2026, an estimated $467K.
  • Clorox made up 0.01% of Brevan Howard Capital Management's portfolio in Q2 2026, its #1010 holding.
  • Brevan Howard Capital Management first reported a position in Clorox in Q4 2023 and has held it in 9 quarters since.
  • Brevan Howard Capital Management's Clorox position peaked at $6.84M in Q2 2025.
  • 1,055 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.